Sanofi nets valuable FDA voucher with approval for first oral regimen for neglected sleeping sicknessnews2021-07-20T14:00:34+00:00July 20th, 2021|Fierce Pharma|
Pfizer yanks 12 Chantix lots on carcinogen concerns after pausing global shipments last monthnews2021-07-20T13:18:14+00:00July 20th, 2021|Fierce Pharma|
Stevanato IPO raises $672M to fund biologics, vaccine deliverynews2021-07-20T12:21:02+00:00July 20th, 2021|Fierce Pharma|
Junshi commits $31M to pact with mRNA delivery specialistnews2021-07-20T12:15:18+00:00July 20th, 2021|Fierce Pharma|
With pandemic restrictions lifted, FDA restarts U.S. inspections and seeks to whittle its massive backlognews2021-07-19T20:13:01+00:00July 19th, 2021|Fierce Pharma|
Curia CEO seized ‘huge open door’ to biologics with back-to-back buyouts of LakePharma, Integrity Bionews2021-07-19T19:26:41+00:00July 19th, 2021|Fierce Pharma|
Johnson & Johnson weighs talc bankruptcy as billions in legal costs pile up: reportnews2021-07-19T15:50:03+00:00July 19th, 2021|Fierce Pharma|
High-profile Biogen ads hype early Alzheimer’s detection as hospitals reject Aduhelm prescriptionsnews2021-07-19T15:24:57+00:00July 19th, 2021|Fierce Pharma|
Don’t forget to nominate 2021’s fiercest women in life sciencesnews2021-07-19T15:23:17+00:00July 19th, 2021|Fierce Pharma|
BioNTech makes a splash in cell therapy with purchase of factory, R&D platform from Gilead’s Kitenews2021-07-19T15:07:22+00:00July 19th, 2021|Fierce Pharma|
